Medical Health & Life Science Research News

Asia-Pacific antiviral drugs market estimated to reach $7.46 billion by 2021 with a CAGR of 6.12% according to new research report

The Asia-Pacific ‘Antiviral Drugs Market' research report, published by Market Data Forecast estimates that the market itself was worth $5.54 billion in 2016 and expected to grow at a CAGR of 6.12%, to reach $7.46 billion by 2021.

- Advertising -

Antivirals are used to treat infections caused by viruses. Unlike antibacterial drugs, which may cover a wide range ofpathogens, antiviral agents tend to be narrow in spectrum, and have limited efficacy.

Exclusive of the antiretroviral agents used in HIV (AIDS) therapy, there are currently only 11 antiviral drugs available,covering four types of virus. Acyclovir (Zovirax), famciclovir (Famvir), and valacyclovir (Valtrex)are effective againstherpesvirus, including herpes zoster and herpes genitalis.

- Advertising -

They may also be of value in either conditions caused byherpes, such as chickenpox and shingles. These drugs are not curative, but may reduce the pain of a herpes outbreakand shorten the period of viral shedding.

Amantadine (Symmetrel), oseltamivir (Tamiflu), rimantidine (Flumadine), and zanamivir (Relenza) are useful in treatmentof influenza virus. Amantadine, rimantadine, and oseltamivir may be administered throughout the flu season aspreventatives for patients who cannot take influenza virus vaccine.

Reportwww.marketdataforecast.com/market-reports/asia-pacific-antiviral-drugs-market-1590/request-sample
Report: www.marketdataforecast.com/cart/asia-pacific-antiviral-drugs-market-1590
The report also presents detailed analysis of multitude of factors affecting the Antiviral Drugs market bearing either positive or negative outcomes. Some of those factors are:
• Increased public awareness
• Rise in healthcare expenditure
• Introduction of new and innovative products
• Increase in viral infection incidences
• Increasing diseased population
• Rising demand for antiviral drugs
• High cost involved in drug development
• Increase in demand for alternative medicines such as naturopathy, homeopathy, and oriental medicines among others
• Majority of population, especially in India and China relying on traditional medicines for treating flu like cold, cough and viral fever.

Report: www.marketdataforecast.com/market-reports/asia-pacific-antiviral-drugs-market-1590/inquire

For granular level understanding the Antiviral Drugs Market is segmented based on product and application, each being provided with Market Size Estimates and Y-o-Y Forecasts. Asia-Pacific Antiviral Drugs Market is segmented on the basis of Application, Target, and End-Users.

Based on Application, the market is classified into HIV/AIDS, Hepatitis, Herpes, Influenza, and Others. On the basis of Target, the market is classified into DNA polymerase, NS3 Protease, Reverse transcriptase, and Others.

On the basis of End-Users, the market is classified into Hospitals, Research Institutes, and Laboratory Centers.

On the basis of geography, the Asia-pacific Antiviral drugs market is segmented into the countries China, India, Japan, and South Korea. The Antiviral drugs market in Asia-Pacific is the fastest growing followed by Latin America.

Report: www.marketdataforecast.com/market-reports/asia-pacific-antiviral-drugs-market-1590/request-discount

The major companies dominating the Antiviral Drugs Market are Johnson & Johnson (USA), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Pfizer (USA), Merck and Co. Inc (USA), GlaxoSmithKline plc (United Kingdom), AstraZeneca AB (United Kingdom), Gilead Sciences (USA), and Abbott Laboratories (USA).

Report: www.marketdataforecast.com/market-reports/asia-pacific-antiviral-drugs-market-1590/customize-report